| Document |
Document Title |
|
WO/1998/029877A1 |
Disclosed is a proton conductor in liquid form, comprised of a mixture of the following components: (a) a salt combined with a nitrogenated base along with an acid, according to formula (I), wherein Z�1?, Z�2?, Z�3?, and Z�4?, wh...
|
|
WO/1998/029389A1 |
The invention is related to ionic compounds, derivatives of malononitrile, in which the anionic load has been displaced. An ionic compound disclosed by the invention includes an anionic portion combined with at least one cationic portion...
|
|
WO/1998/029396A1 |
The invention relates to ionic compounds in which the anionic load has been displaced, and the uses of these compounds. A compound disclosed by the invention comprises an anionic portion combined with at least one cationic portion M?+mï¿...
|
|
WO/1998/029358A2 |
Disclosed is a method for grafting a polymer onto the surface of a carbonate material with carboxyl, amine, and/or hydroxyl functions on its surface. Said material is placed in suspension in a solution including the polymer to be grafted...
|
|
WO/1998/028282A2 |
The present application describes oxygen and sulfur containing heteroaromatics and derivatives thereof of formula (I), or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is O or S and D may be C(=NH)NH�2?, which ar...
|
|
WO/1998/028298A1 |
Ricin A-chain is an N-glycosidase that attacks ribosomal RNA at a higly conserved adenine residue. Crystallographic studies show that not only adenine and formycin, but also pterin-based rings can bind in the ricin active site. For a bet...
|
|
WO/1998/027077A1 |
New compounds of formula (I), in which R stands for (a), (b) or (c); X stands for O or S; and R?1�, R?2�, R?3�, R?4� and n have the meanings given in the first claim, or their tautomeric forms with a closed ring, as well as their...
|
|
WO/1998/027076A1 |
The invention concerns an improved process for preparing 2,1,3-benzothiadiazoles of general formula (I), in which the groups R?1�, R?2�, R?3� and R?4� can be identical or different and designate a hydrogen group or a hydrocarbon ...
|
|
WO/1998/025598A2 |
Methods for inhibiting proliferation of a PPAR$g(g)-responsive hyperproliferative cell using PPAR$g(g) agonists are described. Pharmaceutical compositions as well as methods for diagnosing and treating a PPAR$g(g)-responsive hyperprolife...
|
|
WO/1998/024870A1 |
Novel bleaching compositions comprising a peroxygen compound and an oxygen transfer agent of the structure: R?1�R?2�C=N-SO2-N=CR?3�R?4�. Substrates such as fabrics may be bleached in an aqueous solution containing the oxygen tran...
|
|
WO/1998/023565A2 |
Aminoguanidine and alkoxyguanidine compounds, including compounds of formula $i((I)) wherein X is O or NR?9� and R?1�-R?4�, R?6�-R?9�, R?11�, R?12�, R?a�, R?b�, R?c�, Y, Z, n and m are set forth in the specification, ...
|
|
WO/1998/023155A1 |
Compounds, compositions and methods of use of Formulae (I, IA and IB), their N-oxides and agriculturally suitable salts, as arthropodicides are disclosed. Compounds of Formula (II), useful as intermediates in the preparation of fungicide...
|
|
WO/1998/023156A1 |
Compounds of Formula (I), and their $i(N)-oxides and agriculturally suitable salts, are disclosed which are useful as fungicides and arthropodicides wherein T is (T?1�), (T?2�), (T?3�) or (T?4�); R?3� and R?4� are each indepe...
|
|
WO/1998/022430A1 |
Disclosed are compounds which inhibit $g(b)-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits...
|
|
WO/1998/021186A1 |
The present invention is directed to novel benzothiazo and related heterocyclic group-containing inhibitors of cysteine or serine proteases. Methods for using the same are also described.
|
|
WO/1998/021193A1 |
Compounds, or their compositions, of the general formula: A-(X�1?-NO�2?)�to? or their salts, for the preparation of medicaments for antithrombotic application, where: to is an integer equal to 1 or 2; X�1? is an alkylene connecti...
|
|
WO/1998/020004A1 |
Liquid-crystal compounds which are usable as the basic substance of ferroelectric liquid crystal compositions, have a low viscosity, and exhibit a liquid crystal phase in a low-temperature region; and ferroelectric liquid crystal composi...
|
|
WO/1998/017629A1 |
1,4-Benzoquinone derivatives represented by general formula (I) or pharmacologically acceptable salts thereof: (I) wherein ----- represents a single or double bond; X and Y each represents hydrogen, halogeno, etc.; R?1� and R?2� each...
|
|
WO/1998/017267A1 |
Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or 'linker' defined as including a covalent bond $i(per se) so as to space the aromatic systems at a distance 1.5-15�, are effec...
|
|
WO/1998/014438A1 |
Bisthiadiazole derivatives of general formula (I) and salts thereof, and disease controlling agents containing the derivatives or the salts as the active ingredients, wherein R?1� and R?2� are each H, C�1?-C�8? alkyl, C�1?-C�...
|
|
WO/1998/014437A1 |
1,2,3-Thiadiazole derivatives of general formula (I) and salts thereof, disease controlling agents containing the derivatives or salts as the active ingredients, and a method for the use of the same, wherein R?1� is H, C�1?-C�4? (h...
|
|
WO/1998/012185A1 |
Benzothiadiazide derivatives capable of increasing the synaptic response mediated by AMPA receptors are provided. The subject derivatives find use in a variety of applications in which an increase in AMPA receptor mediated synaptic respo...
|
|
WO/1998/011077A1 |
Chiral compounds of formula (I) where in R�1?, R�2?, R�3?, R�4? = equal or unequal = H, F, Cl, R�5?, R�6? or R�7?; R�5? = CN, NCS, CF�3?, OCF�3?; R�6? = chiral alkyl, alkenyl, alkynyl or fluoroalkyl with chain lengt...
|
|
WO/1998/011078A1 |
Azophane derivatives of formula (1) wherein R�1?, R�2?, R�3?, R�4? = equal or unequal = H, F, Cl, R�5?, R�6? or R�7?; R�5? = CN, NCS, CF�3?, OCF�3?; R�6? = non chiral alkyl, alkenyl, alkynyl or fluoroalkyl with chai...
|
|
WO/1998/009630A1 |
This invention relates to 3,4-dinitrobenzamide compounds which are ligands, in particular, antagonists, of the Calcitonin Gene-Related Peptide ('CGRP') receptor. In addition, this invention relates to the treatment and prevention of dise...
|
|
WO/1998/005659A1 |
Compounds of formula (3), and pharmaceutically acceptable salts and derivatives thereof, in which R?1� is vinyl or ethyl; and R?2� is a group R?3�, R?4�CH�2?-, or R?5�R?6�C=CH-; wherein each of R?3� and R?4� is an azabi...
|
|
WO/1998/001433A1 |
Disclosed are ((4-phenyl-1,2,5-thiadiazol-3-yl)oxy)methyl ester thiocyanic acid compounds corresponding to formula (I) wherein X represents -Br, -Cl, -F, -CF�3?, -OCF�3?, -CN, C�1?-C�7? straight or branched chain alkyl, C�1?-Cï...
|
|
WO/1998/000411A1 |
A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by either of two formulas (I, II). Each of the R groups is defined in the disclosure.
|
|
WO/1997/049692A1 |
1,2,4-Benzothiadiazine derivatives represented by formula (I) wherein D, R1, R2, R3, R4, R5, R12, R13, R14, R15 are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are...
|
|
WO/1997/048688A1 |
The present invention provides novel thiadiazole amide derivatives represented by formula (I). The compounds of the present invention inhibit various enzymes from the matrix metalloproteinase family, predominantly stromelysins, and hence...
|
|
WO/1997/044329A1 |
Cyclic diamines of formula (I) or their pharmacologically acceptable acid addition salts, and their medical applications are described. These compounds inhibit the action of chemokines such as MIP-la and/or MCP-l on target cells, and are...
|
|
WO/1997/043246A1 |
A simple, efficient and high-productivity process for preparing high-quality 1-alkoxycarbonyl-3-phenylpropyl derivatives containing few impurities by catalytic reduction of 1-alkoxycarbonyl-3-oxo-3-phenylpropyl derivatives.
|
|
WO/1997/042167A1 |
The present invention includes processes to prepare commercially important taxols (X) from substituted amino-3-phenyl (2R, 3S) isoserinates (II). In addition processes to prepare the substituted amino-3-phenyl (2R, 3S) insoserinates (II)...
|
|
WO/1997/041130A2 |
The present invention provides a method for sulfurizing a phosphorus-containing compound, such as a trivalent phosphorus compound, using a disulfide-containing five-membered heterocycle.
|
|
WO/1997/040044A1 |
The present invention provides heterocyclic compounds which are useful for modulating a muscarinic receptor.
|
|
WO/1997/040031A1 |
The present invention provides novel thiadiazole derivatives represented by formula (I) or pharmaceutical acceptable salts thereof wherein the compounds of the present invention inhibit various enzymes from the matrix metalloproteinase f...
|
|
WO/1997/040017A2 |
The present invention relates to novel organic compounds, to methods for their preparation, to compositions containing them, to their use for treatment of human and animal disorders, to their use for purification of proteins or glycoprot...
|
|
WO/1997/036580A1 |
Amidino and benzamidino compounds, including compounds of formula (I), wherein R1-R4, R6-R9, Y, Z, n and m are set forth in the specification, as well as hydrates, solvates or pharmaceutically acceptable salts thereof, that inhibit prote...
|
|
WO/1997/035929A1 |
Compositions containing conductivity enhancers, which are capable of being coated onto a substrate by means of electrostatic assistance. The compositions comprise one or more cationically polymerizable monomer(s), one or more cationic in...
|
|
WO/1997/031893A1 |
Thiols are trapped, and converted to disulfide compounds, by a process of reacting them with compounds containing a 1,2,4-thiadiazole ring structure carrying a substituent at position 3 of the thiadiazole ring, and being unsubstituted at...
|
|
WO/1997/031909A1 |
The invention relates to a process for the preparation of cyclic perfluoroalkanebis(sulfonyl)imides and salts thereof. The new compound lithium cyclodifluoromethanebis(sulfonyl)imide is outstandingly suitable as a conductive salt in non-...
|
|
WO/1997/030982A1 |
The invention concerns compounds of formula (I), in which R is (i), (ii) or (iii); n is 0, 1 or 2; X means O or S; and R1, R2, R3 and R4 have different meanings, or a cyclized tautomeric shape. The invention also concerns the (E) isomers...
|
|
WO/1997/030038A1 |
Compounds represented by the following general formula: A-C(X)(Y)-C(R1)(R2)-Z wherein Z represents, for example, -N(R3)-(CH2)p-B [wherein R3 represents alkyl, etc.; p is an integer of from 3 to 8; and B represents a group represented by ...
|
|
WO/1997/029097A1 |
The invention relates to compounds having 5HT7 antagonist activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.
|
|
WO/1997/026884A1 |
This invention is a novel treatment for sexual dysfunctions by administering to a subject exhibiting a sexual dysfunction compounds that upmodulate the AMPA receptor. Methods and compositions for treating sexual dysfunction are provided....
|
|
WO/1997/027180A1 |
This invention relates to a novel class of compounds of formula (I) that are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of aspartyl protease inhibitors characterized by specific structural an...
|
|
WO/1997/026252A1 |
Compounds of structure (a) are disclosed as effective insecticides, in which: A and B are independently lower alkyl; U is lower alkylidene, lower alkenylidene, or CH-Z, where Z is hydrogen, lower alkyl, lower cycloalkyl, or phenyl; R is ...
|
|
WO/1997/026240A1 |
Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure (I) or (IA) or (IB) including pharmaceutically acceptable sa...
|
|
WO/1997/026251A1 |
The invention concerns novel acylated 5-amino-1,2,4-thiadiazoles of formula (I) in which R1, R2, R3 and Y have the meanings given in the description. The invention further concerns a process for their preparation, and their use as pestic...
|
|
WO/1997/025318A1 |
Compounds of formula (I), in which R1, R2 and R3 are as defined in claim 1, are particularly suitable as herbicides.
|
